Published in

Springer Nature [academic journals on nature.com], Leukemia, 7(34), p. 1775-1786, 2020

DOI: 10.1038/s41375-019-0700-9

Links

Tools

Export citation

Search in Google Scholar

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

Journal article published in 2020 by G. A. Horne ORCID, J. Stobo ORCID, C. Kelly, A. Mukhopadhyay, A. L. Latif, J. Dixon-Hughes, L. McMahon, P. Cony-Makhoul, J. Byrne ORCID, G. Smith, S. Koschmieder ORCID, T. H. BrÜmmendorf, P. Schafhausen, P. Gallipoli ORCID, F. Thomson and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO